跳至主要内容
临床试验/NCT01599962
NCT01599962已完成2 期

Influence of Cincalcet on Cognitive Functions in Healthy Human Subjects

Prof. Dominique de Quervain, MD1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2012年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Change of attention functions under cinacalcet

研究概览

简要总结

To investigate the effects of the calcimimetic agent cinacalcet on cognitive functions in healthy humans.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • normotensive
  • native or fluent German-speaking
  • caucasian (European ancestry)
  • BMI between 19 and 27 kg/m2

排除标准

  • acute or chronic psychiatric or somatic disorder
  • pathological ECG
  • Low serum calcium
  • known hypersensitivity to the IMP
  • pregnancy
  • breast-feading
  • long-term medication within last 3 months
  • smoking more than 3 cigarettes per day
  • seizures in participants and first degree relatives
  • concurrent participation in another study

研究组 & 干预措施

Cinacalcet

Experimental

干预措施: Cinacalcet (Drug)

Sugar pill

Placebo Comparator

干预措施: Cinacalcet (Drug)

Sugar pill

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

Change of attention functions under cinacalcet

时间窗: two study days within 10 days

Change of memory functions under cinacalcet

时间窗: two testing days within 10 days

次要结局

  • Change of emotional state under cinacalcet(two study days within 10 days)

研究者

发起方
Prof. Dominique de Quervain, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Prof. Dominique de Quervain, MD

Director of the Division of Cognitive Neuroscience

University of Basel

研究点 (1)

Loading locations...

相似试验